Francis Chi
Vorstandsvorsitzender bei WALCOM GROUP LIMITED
Profil
Francis Chi is the founder of Obio Pharmaceutical Holdings Ltd.
He is currently the CEO, CFO & Executive Director at Walcom Group Ltd.
and the Director at Antiviral Technologies, Inc. Previously, he served as the Managing Director at Becoin Ltd.
and the Sales Manager at Listo Enterprises Co. Ltd.
Mr. Chi obtained his undergraduate degree from Seattle University in 1984.
Aktive Positionen von Francis Chi
| Unternehmen | Position | Beginn |
|---|---|---|
| WALCOM GROUP LIMITED | Vorstandsvorsitzender | 01.01.2004 |
Antiviral Technologies, Inc.
 Antiviral Technologies, Inc. Financial ConglomeratesFinance Antiviral Technologies, Inc. operates as a development stage biotechnology company utilizing cysteamine compositions in the development of antiviral drugs for human application. It operates business through subsidiary Obio Pharmaceutical (HK) Ltd. The company has offices in Beijing and Hong Kong. Antiviral Technologies was founded on September 13, 2007 and is headquartered in Hong Kong. | Direktor/Vorstandsmitglied | 05.04.2010 |
Obio Pharmaceutical Holdings Ltd.
 Obio Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Obio Pharmaceutical Holdings Ltd. is a holding There is no available country named vg company with interests in the pharmaceutical business. The private company was founded by Francis Chi. | Gründer | - |
Ehemalige bekannte Positionen von Francis Chi
| Unternehmen | Position | Ende |
|---|---|---|
| Becoin Ltd. | Corporate Officer/Principal | 01.01.1990 |
| Listo Enterprises Co. Ltd. | Vertrieb & Marketing | 01.01.1986 |
Ausbildung von Francis Chi
| Seattle University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Antiviral Technologies, Inc.
Antiviral Technologies, Inc. Financial ConglomeratesFinance Antiviral Technologies, Inc. operates as a development stage biotechnology company utilizing cysteamine compositions in the development of antiviral drugs for human application. It operates business through subsidiary Obio Pharmaceutical (HK) Ltd. The company has offices in Beijing and Hong Kong. Antiviral Technologies was founded on September 13, 2007 and is headquartered in Hong Kong. | Finance |
Walcom Group Ltd.
 Walcom Group Ltd. Pharmaceuticals: GenericHealth Technology Walcom Group Ltd. is a holding company, which engages in the research, development, commercialization, production and marketing of animal feed additive products. Its products include Porcinin Plus, Porcimax, Eggronin Plus, and Aquanin Plus. It operates through the following geographical segments: Hong Kong, China, Philippines, Thailand, Taiwan, Other Asia-Pacific Countries, Europe and the United Kingdom, America and Canada, and Others. The company was founded in 2004 and is headquartered in Shanghai, China. | Health Technology |
| Becoin Ltd. | |
| Listo Enterprises Co. Ltd. | |
Obio Pharmaceutical Holdings Ltd.
Obio Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Obio Pharmaceutical Holdings Ltd. is a holding There is no available country named vg company with interests in the pharmaceutical business. The private company was founded by Francis Chi. | Health Technology |
